지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Localized cancer immunotherapy using bioinspired therapeutic antibody-releasing immuno-glue
한국생물공학회 학술대회
2019 .10
Engineering of tumor microenvironment on a chip for evaluating combination immunotherapy
대한기계학회 춘추학술대회
2021 .04
A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity
BMB Reports
2020 .01
Enhancing Cancer Immunotherapy using Biomaterials
한국생물공학회 학술대회
2019 .10
Photothermal Therapy and Neoantigen Vaccine for Cancer Nano-immunotherapy
한국고분자학회 학술대회 연구논문 초록집
2021 .10
T Cell-mimicking Nanoparticles for Cancer Immunotherapy
한국고분자학회 학술대회 연구논문 초록집
2021 .04
Cancer Immunotherapy Platform Using Human Ferritin Protein Nanoparticle
한국생물공학회 학술대회
2021 .04
Development of Tumor Microenvironment-Modulating Nanoparticles for Improved Anti-Tumor Efficacy of Immunotherapy
한국고분자학회 학술대회 연구논문 초록집
2022 .04
Development of RNA Structures for Cancer Immunotherapy
한국생물공학회 학술대회
2022 .09
암 치료를 위한 항체치료제에 대한 고찰: 면역항암제
KSBB Journal
2020 .06
Current Immunotherapy Approaches for Malignant Melanoma
BioChip Journal
2019 .01
Biomedical Application of Polypeptide for Cancer Immunotherapy
한국생물공학회 학술대회
2022 .04
Cancer immunotherapy: special issue of BMB Reports in 2021
BMB Reports
2021 .01
Research progress on hydrogel-based drug therapy in melanoma immunotherapy
BMB Reports
2024 .02
Development of Human PD-1 Specific Repebody for Cancer Immunotherapy
한국생물공학회 학술대회
2019 .04
Enhancing Cancer Immunotherapy Using Biomaterials
한국고분자학회 학술대회 연구논문 초록집
2018 .10
Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications
Nano Convergence
2022 .04
Metabolic reprogramming of the tumor microenvironment to enhance immunotherapy
BMB Reports
2024 .09
Modification of immune cell-derived exosomes for enhanced cancer immunotherapy: current advances and therapeutic applications
Experimental and Molecular Medicine
2024 .01
0